TG Therapeutics | TGTX - Выручка от реализации





Продажи Изменить Дата
AbbVie USD 15B 1.62B 2026-03
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 9.9B 340M 2025-12
Ardelyx USD 125.21M 14.89M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
Biogen USD 2.25B 30M 2026-03
Corcept Therapeutics USD 202.12M 5.48M 2025-12
Curis USD 1.14M 1.41M 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
Infinity Pharmaceuticals USD 583K 148K 2023-06
J&J USD 24.1B 500M 2026-03
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Novartis USD 13.11B 226M 2026-03
Novavax USD 147.14M 76.69M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
TG Therapeutics USD 192.57M 30.87M 2025-12
Verastem USD 17.54M 7.53M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12